Fusion Antibodies announce partnership with ISCA diagnostics

Fusion Antibodies CDRx platform has rapidly developed high quality humanized antibodies for Exeter based company Isca Diagnostics.

The EU funded project will allow ISCA Diagnostics to provide the healthcare profession with easy access to rapid and accurate diagnostic tests for human mycoses.

More details of the collaboration can be found on our recent press release on the Press Release at

http://uk.prweb.com/releases/FusionAntibodies/AntibodyHumanization/prweb11236850.htm